| P50 | author | Keith Muir | Q73007450 |
| P2093 | author name string | Muir KW | |
| P2860 | cites work | Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels | Q24537389 |
| | Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex | Q24682445 |
| | Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial | Q24804442 |
| | Magnesium gates glutamate-activated channels in mouse central neurones | Q29616237 |
| | Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia | Q31931462 |
| | Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist | Q33888681 |
| | Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators | Q33925384 |
| | Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls? | Q73906879 |
| | Neuroprotection for acute stroke: making clinical trials work | Q77765121 |
| | Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model | Q77950029 |
| | Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage | Q78110194 |
| | Magnesium: Nature's physiologic calcium blocker | Q34257784 |
| | Cerestat and other NMDA antagonists in ischemic stroke | Q34446525 |
| | Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness | Q34458392 |
| | Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials | Q35181897 |
| | Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system | Q37697556 |
| | Magnesium metabolism: a review | Q40293250 |
| | Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials | Q41210382 |
| | Effect of Magnesium on Epileptic Foci | Q41365710 |
| | Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats | Q41850282 |
| | Effect of changing extracellular levels of magnesium on spontaneous activity and glutamate release in the mouse neocortical slice | Q42111312 |
| | Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy | Q43468347 |
| | Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients | Q44053916 |
| | Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies | Q46892739 |
| | Effect of parenteral magnesium sulfate administration on excitatory amino acid receptors in the rat brain. | Q47797149 |
| | Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia | Q48238644 |
| | Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures | Q48322532 |
| | Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study | Q48431907 |
| | Dose optimization of intravenous magnesium sulfate after acute stroke | Q48465392 |
| | Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats | Q48626944 |
| | Magnesium sulphate improves neurologic outcome following severe closed head injury in rats | Q48683992 |
| | Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia | Q48931177 |
| | Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications | Q48957319 |
| | Have randomized controlled trials of neuroprotective drugs been underpowered? An illustration of three statistical principles | Q48960167 |
| | Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. | Q49079710 |
| | Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats | Q49103959 |
| | Magnesium exchange between blood and cerebrospinal fluid. | Q51282677 |
| | Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study. | Q51360850 |
| | Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat. | Q51403354 |
| | Getting the chemistry right in trials. | Q51459541 |
| | Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. | Q51535412 |
| | Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. | Q51568429 |
| | Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. | Q51568433 |
| | Magnesium is more efficacious than phenytoin in reducing N-methyl-D-aspartate seizures in rats. | Q51623692 |
| | NMDA receptor blockade and spinal cord ischemia due to aortic crossclamping in the rat model. | Q51627874 |
| | Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats. | Q51651739 |
| | Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-L-arginine methyl ester, in conscious rats. | Q51658578 |
| | Effect of magnesium sulfate on the vascular actions of norepinephrine and angiotensin II. | Q51684167 |
| | Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) | Q51689005 |
| | A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. | Q51836701 |
| | Failure to anesthetize human subjects by intravenous administration of magnesium sulfate | Q52757694 |
| | Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease. | Q54370104 |
| | Tissue-specific modulation of the mitochondrial calcium uniporter by magnesium ions | Q58454403 |
| | Effects of magnesium sulfate on brain damage by complete global brain ischemia | Q68092213 |
| | Magnesium protects against neurological deficit after brain injury | Q69737394 |
| | Magnesium inhibits platelet activity--an infusion study in healthy volunteers | Q71570258 |
| | Different Effects of Mg2+ on Endothelin-1− and 5-Hydroxytryptamine-Elicited Responses in Goat Cerebrovascular Bed | Q71651967 |
| | Glutamate-induced increases in intracellular free Mg2+ in cultured cortical neurons | Q72233113 |
| | Thresholds in cerebral ischemia - the ischemic penumbra | Q72913488 |
| | NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801 | Q73605159 |
| P433 | issue | 925 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | magnesium | Q660 |
| P304 | page(s) | 641-645 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Postgraduate Medical Journal | Q7234294 |
| P1476 | title | Magnesium in stroke treatment | |
| P478 | volume | 78 | |